Key result
Lower eGDR is linked to a ~3.4-fold higher risk of in-stent restenosis after NSTE-ACS PCI.
Why the study?
The predictive power of estimated glucose disposal rate (eGDR) for in-stent restenosis after PCI in NSTE-ACS patients remains unclear.
Does the estimated glucose disposal rate (eGDR) predict in-stent restenosis in patients with NSTE-ACS following PCI?
Observational (n=1,218)
No
Does the estimated glucose disposal rate (eGDR) predict in-stent restenosis in patients with NSTE-ACS following PCI?
Odds Ratio: 3.393 (95% CI 2.099–5.488)
p-value: p=<0.001
The estimated glucose disposal rate (eGDR), a simple marker of insulin resistance, provides independent and incremental predictive value for in-stent restenosis in patients with NSTE-ACS undergoing PCI.
eGDR may refine restenosis risk assessment after PCI in NSTE-ACS; leaves open prospective validation before clinical adoption.
Background Insulin resistance (IR) is closely associated with in-stent restenosis (ISR) following percutaneous coronary intervention (PCI). Nevertheless, the predictive power of the newly developed simple assessment of IR, estimated glucose disposal rate (eGDR), for ISR after PCI in individuals with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) remains unclear. Methods Based on eligibility criteria, 1218 NSTE-ACS cases administered PCI in Beijing Anzhen Hospital Between January and December 2015 were included. The included individuals were submitted to at least one coronary angiography within 48 months after discharge. Patients were assigned to 2 groups according to ISR occurrence or absence. eGDR was derived as 21.16 - (0.09 * waist circumference [cm]) - (3.41 * hypertension) - (0.55 * glycated hemoglobin [%]). Multivariate logistic regression analysis model and receiver operating characteristic (ROC) curve analysis was established for evaluating eGDR’s association with ISR. Results In multivariate logistic analysis, the odds ratios (ORs) of eGDR as a nominal variate and a continuous variate were 3.393 (confidence interval [CI] 2.099–5.488, P < 0.001) and 1.210 (CI 1.063–1.378, P = 0.004), respectively. The incremental effect of eGDR on ISR prediction based on traditional cardiovascular risk factors was reflected by ROC curve analysis (AUC: baseline model + eGDR 0.644 vs. baseline model 0.609, P for comparison = 0.013), continuous net reclassification improvement (continuous-NRI) of -0.264 (p < 0.001) and integrated discrimination improvement (IDI) of 0.071 (p = 0.065). Conclusion In NSTE-ACS cases administered PCI, eGDR levels are independently negatively associated with increased ISR risk.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2022) conducted an observational in Non-ST-segment elevation acute coronary syndrome (n=1,218). Estimated glucose disposal rate (eGDR) vs. Higher eGDR was evaluated on In-stent restenosis (ISR) (OR 3.393, 95% CI 2.099-5.488, p=<0.001). Lower estimated glucose disposal rate was independently associated with an increased risk of in-stent restenosis (OR 3.393) following percutaneous coronary intervention in patients with NSTE-ACS.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: